An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.

NCT00301574 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

398

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: galantamine

Sponsor

Janssen Pharmaceutical K.K.